Burning Rock Biotech (BNR) Return on Invested Capital (2022 - 2026)

Burning Rock Biotech (BNR) has reported Return on Invested Capital for 5 consecutive years, with 0.0% the latest figure, recorded in Q1 2026.

• In Q1 2026, Return on Invested Capital changed 0.0% year-over-year to 0.0%; the TTM figure through Mar 2026 stood at 0.0% (changed 0.0% YoY), while the FY2025 annual figure was 0.0%, changed 0.0% from the prior year.
• Return on Invested Capital came in at 0.0% for Q1 2026 at Burning Rock Biotech, down from 0.0% in the prior quarter.
• The five-year high for Return on Invested Capital was 0.0% in Q4 2025, with the low at 0.01% in Q4 2022.
• Average Return on Invested Capital over 5 years is 0.01%, with a median of 0.01% recorded in 2023.
• Across the five-year window, Return on Invested Capital changed 0 bps in 2023 and grew 1 bps in 2025, its largest moves.
• Year by year, Return on Invested Capital stood at 0.01% in 2022, then climbed by 1 bps to 0.01% in 2023, then surged by 33 bps to 0.01% in 2024, then surged by 83 bps to 0.0% in 2025, then dropped by 10 bps to 0.0% in 2026.
• According to Business Quant data, Return on Invested Capital over the past three periods registered 0.0%, 0.0%, and 0.0% for Q1 2026, Q4 2025, and Q3 2025 respectively.